<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/global/feed/rss.xslt" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podaccess="https://access.acast.com/schema/1.0/" xmlns:acast="https://schema.acast.com/1.0/">
    <channel>
		<ttl>60</ttl>
		<generator>acast.com</generator>
		<title>eDiabetes Review</title>
		<link>https://podcast.dkbmed.com/category/ediabetes/</link>
		<atom:link href="https://feeds.acast.com/public/shows/5fa6e50e5686194f10370b5d" rel="self" type="application/rss+xml"/>
		<language>en</language>
		<copyright>DKBmed 2019</copyright>
		<itunes:keywords/>
		<itunes:author>eDiabetes Review</itunes:author>
		<itunes:subtitle>eDiabetes Review podcast channel</itunes:subtitle>
		<itunes:summary><![CDATA[eDiabetes Review podcast brings the journal club to you. Our moderator and expert faculty members analyze recently published and clinically relevant literature and then explain, with real-world case presentations, how you can apply the new data to your practice. Stay up to date on the rapidly changing world of diabetes while earning CME credits. All available at no cost or prerequisite and on your schedule.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		<description><![CDATA[eDiabetes Review podcast brings the journal club to you. Our moderator and expert faculty members analyze recently published and clinically relevant literature and then explain, with real-world case presentations, how you can apply the new data to your practice. Stay up to date on the rapidly changing world of diabetes while earning CME credits. All available at no cost or prerequisite and on your schedule.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
		<itunes:explicit>false</itunes:explicit>
		<itunes:owner>
			<itunes:name>eDiabetes Review</itunes:name>
			<itunes:email>info+5fa6e50e5686194f10370b5d@mg-eu.acast.com</itunes:email>
		</itunes:owner>
		<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
		<acast:showUrl>ediabetesreview</acast:showUrl>
		<acast:signature key="EXAMPLE" algorithm="aes-256-cbc"><![CDATA[wbG1Z7+6h9QOi+CR1Dv0uQ==]]></acast:signature>
		<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmTHg2/BXqPr07kkpFZ5JfhvEZqggcpunI6E1w81XpUaBscFc3skEQ0jWG4GCmQYJ66w6pH6P/aGd3DnpJN6h/CD4icd8kZVl4HZn12KicA2k]]></acast:settings>
        <acast:network id="600766a7795a1c638da174e7" slug="dkbmed-dkbmed"><![CDATA[DKBmed DKBmed]]></acast:network>
		<acast:importedFeed>https://podcast.dkbmed.com/feed/ediabetes/</acast:importedFeed>
		<itunes:type>episodic</itunes:type>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<image>
				<url>https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg</url>
				<link>https://podcast.dkbmed.com/category/ediabetes/</link>
				<title>eDiabetes Review</title>
			</image>
			<itunes:new-feed-url>https://feeds.acast.com/public/shows/5fa6e50e5686194f10370b5d</itunes:new-feed-url>
		<item>
			<title>In the Clinic: The New Ultralong-Acting Insulins</title>
			<itunes:title>In the Clinic: The New Ultralong-Acting Insulins</itunes:title>
			<pubDate>Thu, 11 Oct 2018 14:15:51 GMT</pubDate>
			<itunes:duration>25:54</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D200/media.mp3" length="31077355" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=200</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a4</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a4</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRL1HPtcXNX3mGtLDfe+Lx3Z]]></acast:settings>
			<itunes:subtitle>Scenarios in which patients can benefit from ultralong-acting insulins. The potential negatives of ultralong-acting insulins.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608154556372-a3addae5d07bc2199c70577740c48824.jpeg"/>
			<description><![CDATA[<p>In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#374">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#375">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-11.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#374">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#375">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-11.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Clinical Implications of CGM in Patients with Type 2</title>
			<itunes:title>Clinical Implications of CGM in Patients with Type 2</itunes:title>
			<pubDate>Tue, 14 Aug 2018 06:00:09 GMT</pubDate>
			<itunes:duration>25:54</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D158/media.mp3" length="31077355" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=158</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a5</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a5</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRK2lA6wPdg2u+Z8ESimJMw+]]></acast:settings>
			<itunes:subtitle>How to interpret CGM data reports using ambulatory glucose profiles (AGP). Differences between “flash” CGM and “real time” CGM.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608154805636-877a8c65d148ab410f58219ffd02b5a8.jpeg"/>
			<description><![CDATA[<p>In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#351">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#352">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-9.html">click here</a>.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#351">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#352">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-9.html">click here</a>.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Intensifying Glycemic Therapy with a Fixed Ratio Basal Insulin/GLP-1 RA Combination</title>
			<itunes:title>Intensifying Glycemic Therapy with a Fixed Ratio Basal Insulin/GLP-1 RA Combination</itunes:title>
			<pubDate>Tue, 10 Jul 2018 06:00:32 GMT</pubDate>
			<itunes:duration>28:45</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D155/media.mp3" length="34492081" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=155</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a6</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a6</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKI+rFDIymkJT1zk8Ouizme]]></acast:settings>
			<itunes:subtitle>The use of a GLP-1RA as add-on or in a fixed ratio combination (FRC) as an intensification strategy after basal insulin.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608154969812-6f6910a28b0732727d34150ba14d9fd0.jpeg"/>
			<description><![CDATA[<p>In this podcast Dr. Anders Carlson from the University of Minnesota Medical School discusses the clinical implications of continuous glucose monitoring (CGM) in patients with type 2 diabetes.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#346">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#345">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-7.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast Dr. Anders Carlson from the University of Minnesota Medical School discusses the clinical implications of continuous glucose monitoring (CGM) in patients with type 2 diabetes.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#346">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#345">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-7.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Clinical Insights: Management of Type 2 Diabetes in Older Adults</title>
			<itunes:title>Clinical Insights: Management of Type 2 Diabetes in Older Adults</itunes:title>
			<pubDate>Wed, 04 Apr 2018 06:00:32 GMT</pubDate>
			<itunes:duration>31:24</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D146/media.mp3" length="37681632" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=146</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a7</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a7</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRK1rWddVuyT/uX+jVrd3nH6]]></acast:settings>
			<itunes:subtitle> Appropriate screening related to both chronic diabetes complications as well as general health for older adults with diabetes. Medication management in older adults with multiple comorbidities, including renal insufficiency.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608156572679-db16d208a85a286c4f957866853190b2.jpeg"/>
			<description><![CDATA[<p>In this podcast Drs. Amisha Wallia and Susan Karam discuss clinical insights to managing elderly patients with T2DM.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#310">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#311">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-5.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast Drs. Amisha Wallia and Susan Karam discuss clinical insights to managing elderly patients with T2DM.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#310">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#311">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-5.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Insulin Intensification with OADs</title>
			<itunes:title>Insulin Intensification with OADs</itunes:title>
			<pubDate>Fri, 09 Feb 2018 06:00:52 GMT</pubDate>
			<itunes:duration>25:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D143/media.mp3" length="30965551" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=143</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a8</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a8</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKe8iogaXqGt3k2Yl4tlAFA]]></acast:settings>
			<itunes:subtitle>Considerations for patients on insulin monotherapy who have advanced chronic kidney disease. How to add oral agents to insulin monotherapy to maximize clinical benefit while minimizing risk.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608155416493-ebc9f0ceb355469b0abcd7d1b6dcf534.jpeg"/>
			<description><![CDATA[<p>In this podcast Dr. Clare Lee from Johns Hopkins discussed Insulin Intensification with OADs.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#291">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#292">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-3.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast Dr. Clare Lee from Johns Hopkins discussed Insulin Intensification with OADs.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#291">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#292">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-3.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Cardiovascular Outcomes in Type 2 Diabetes Management</title>
			<itunes:title>Cardiovascular Outcomes in Type 2 Diabetes Management</itunes:title>
			<pubDate>Thu, 28 Dec 2017 06:00:10 GMT</pubDate>
			<itunes:duration>34:51</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D132/media.mp3" length="41823608" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=132</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331a9</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331a9</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRIZxgIA7LBjh1/9RKwrfdm9]]></acast:settings>
			<itunes:subtitle>Antidiabetic regimens that optimize cardiovascular benefits and reduce overall CV risk for patients with underlying CAD and PVD.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608155600873-d5253f04a2f0562ca86055ea91611665.jpeg"/>
			<description><![CDATA[<p>In this podcast, Dr. Nestoras Mathioudakis from Johns Hopkins University School of Medicine discusses how the focus on cardiovascular outcomes can impact current clinical practice when managing patients with type 2 diabetes.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#263">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#278">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-1.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this podcast, Dr. Nestoras Mathioudakis from Johns Hopkins University School of Medicine discusses how the focus on cardiovascular outcomes can impact current clinical practice when managing patients with type 2 diabetes.</p><p></p><p>Take our post-test to claim CME credits:Physician <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#263">post-test</a>Nurse <a href="http://dkbmedstream.com/postTestSystem/tests/index.php#278">post-test</a></p><p></p><p>To read a companion newsletter <a href="http://ediabetesreview.org/newsletters/volume-3/ediab-volume-3-issue-1.html">click here</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Dietary Recommendations for Patients with Diabetes</title>
			<itunes:title>Dietary Recommendations for Patients with Diabetes</itunes:title>
			<pubDate>Thu, 15 Sep 2016 06:00:09 GMT</pubDate>
			<itunes:duration>32:20</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D479/media.mp3" length="38801810" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=479</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331aa</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331aa</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRLMcv7WiMvrqtv/WJU4axvw]]></acast:settings>
			<itunes:subtitle>How to counsel patients about the appropriateness of commercially available and medically endorsed diets for diabetes management. The effects of alcohol on glycemic control in type 2 diabetes.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1608156444160-0205e0a1891886966b09a019dfebf292.jpeg"/>
			<description><![CDATA[Nestoras Mathioudakis, MD covers the important topic of the Dietary Recommendations for Patients with Diabetes in the format of case-study scenarios for the clinical practice.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[Nestoras Mathioudakis, MD covers the important topic of the Dietary Recommendations for Patients with Diabetes in the format of case-study scenarios for the clinical practice.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)</title>
			<itunes:title>Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)</itunes:title>
			<pubDate>Thu, 25 Aug 2016 06:02:35 GMT</pubDate>
			<itunes:duration>9:31</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D481/media.mp3" length="2289156" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=481</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331ab</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331ab</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRLtXof7f0SlrpZeI9GAevhs]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 13, Part 3. Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Gl...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 3.</em></p><p>Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-3/">Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 3.</em></p><p>Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-3/">Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care</title>
			<itunes:title>A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care</itunes:title>
			<pubDate>Thu, 25 Aug 2016 06:01:23 GMT</pubDate>
			<itunes:duration>12:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D483/media.mp3" length="2904420" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=483</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331ac</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331ac</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKiMgJlnCzrpS55meWEUi0S]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 13, Part 2. Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in ...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 2.</em></p><p>Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-2/">A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 2.</em></p><p>Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-2/">A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Inpatient Glycemic Management: From the Bedside to the Cloud</title>
			<itunes:title>Inpatient Glycemic Management: From the Bedside to the Cloud</itunes:title>
			<pubDate>Thu, 25 Aug 2016 06:00:41 GMT</pubDate>
			<itunes:duration>8:54</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D485/media.mp3" length="2144680" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=485</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331ad</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331ad</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKWfZGic4qqFVE1r9VkmRzV]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 13, Part 1. Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific a...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 1.</em></p><p>Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-1/">Inpatient Glycemic Management: From the Bedside to the Cloud</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 13, Part 1.</em></p><p>Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-13-1/">Inpatient Glycemic Management: From the Bedside to the Cloud</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Risks and Benefits of SGLT-2 Inhibitor Agents</title>
			<itunes:title>Risks and Benefits of SGLT-2 Inhibitor Agents</itunes:title>
			<pubDate>Thu, 30 Jun 2016 06:00:07 GMT</pubDate>
			<itunes:duration>31:55</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D487/media.mp3" length="38292943" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=487</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331ae</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331ae</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRINy+0NEzoAmUiOLFyfs7Zb]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 11. Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 11.</em></p><p>Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-11/">Risks and Benefits of SGLT-2 Inhibitor Agents</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 11.</em></p><p>Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-11/">Risks and Benefits of SGLT-2 Inhibitor Agents</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>The Clinical Use of Fixed-Dose OADs</title>
			<itunes:title>The Clinical Use of Fixed-Dose OADs</itunes:title>
			<pubDate>Thu, 28 Apr 2016 06:00:27 GMT</pubDate>
			<itunes:duration>28:25</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D490/media.mp3" length="34109164" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=490</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331af</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331af</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRI+GKAKFsF16DMDnA4QBJiJ]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 9. Clare J. Lee, MD, MHS covers the important topic of the Clinical Use of Fixed-Dose OADs in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 9.</em></p><p>Clare J. Lee, MD, MHS covers the important topic of the Clinical Use of Fixed-Dose OADs in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-9/">The Clinical Use of Fixed-Dose OADs</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 9.</em></p><p>Clare J. Lee, MD, MHS covers the important topic of the Clinical Use of Fixed-Dose OADs in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-9/">The Clinical Use of Fixed-Dose OADs</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Safety of the Newer Oral Diabetes Treatment Agents</title>
			<itunes:title>Safety of the Newer Oral Diabetes Treatment Agents</itunes:title>
			<pubDate>Thu, 25 Feb 2016 06:00:45 GMT</pubDate>
			<itunes:duration>25:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D492/media.mp3" length="30842823" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=492</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b0</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b0</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRI70TCjrkgfqihMQG4w6uv5]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 7. Marc Rendell, MD covers the important topic of the Safety of the Newer Oral Diabetes Treatment Agents in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 7.</em></p><p>Marc Rendell, MD covers the important topic of the Safety of the Newer Oral Diabetes Treatment Agents in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-7/">Safety of the Newer Oral Diabetes Treatment Agents</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 7.</em></p><p>Marc Rendell, MD covers the important topic of the Safety of the Newer Oral Diabetes Treatment Agents in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-7/">Safety of the Newer Oral Diabetes Treatment Agents</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Improving Patient-Centered Care in the Clinic</title>
			<itunes:title>Improving Patient-Centered Care in the Clinic</itunes:title>
			<pubDate>Tue, 29 Dec 2015 06:00:07 GMT</pubDate>
			<itunes:duration>26:40</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D494/media.mp3" length="32006310" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=494</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b1</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b1</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKUtBK4bu7NAXu82Svz6cQZ]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 5. Susan Porter, MSN, CRNP, CDE covers the important topic of patient-centered care in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 5.</em></p><p>Susan Porter, MSN, CRNP, CDE covers the important topic of patient-centered care in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-5/">Improving Patient-Centered Care in the Clinic</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 5.</em></p><p>Susan Porter, MSN, CRNP, CDE covers the important topic of patient-centered care in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-5/">Improving Patient-Centered Care in the Clinic</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination</title>
			<itunes:title>Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination</itunes:title>
			<pubDate>Thu, 29 Oct 2015 06:00:24 GMT</pubDate>
			<itunes:duration>25:33</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D497/media.mp3" length="30658918" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=497</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b2</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b2</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRI8IrTs9iyEE0oZmViZuJoK]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 3. Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 3.</em></p><p>Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-3/">Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 3.</em></p><p>Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-3/">Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 3</title>
			<itunes:title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 3</itunes:title>
			<pubDate>Wed, 02 Sep 2015 06:00:35 GMT</pubDate>
			<itunes:duration>7:50</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D499/media.mp3" length="7513651" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=499</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b3</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b3</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKAk7zqIbjqgv+pP79tG2/F]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 1 – Part  3. Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  3.</em></p><p>Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-3/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 3</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  3.</em></p><p>Kathleen Dungan, MD, MPH covers the important topic of GLP-1 Receptor Agonists in Combination in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-3/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 3</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 2</title>
			<itunes:title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 2</itunes:title>
			<pubDate>Wed, 02 Sep 2015 06:00:24 GMT</pubDate>
			<itunes:duration>5:06</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D501/media.mp3" length="6126282" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=501</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b4</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b4</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKto1ELfMDtqSg+zSEZqRLX]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 1 – Part  2. Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Jennifer Green from Duke University Medical Center about the TECOS study.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  2.</em></p><p>Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Jennifer Green from Duke University Medical Center about the TECOS study.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-2/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 2</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  2.</em></p><p>Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Jennifer Green from Duke University Medical Center about the TECOS study.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-2/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 2</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 1</title>
			<itunes:title>2015 ADA AND AACE CONFERENCE HIGHLIGHTS – Part 1</itunes:title>
			<pubDate>Wed, 02 Sep 2015 06:00:13 GMT</pubDate>
			<itunes:duration>4:21</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D503/media.mp3" length="5212520" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=503</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b5</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b5</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKBS+a+aQVXH6ErpMJdk0RV]]></acast:settings>
			<itunes:subtitle>Volume 2, Issue 1 – Part  1. Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Andrew Ahmann from the Oregon Health and Science University about the FLAT-SUGAR trial.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  1.</em></p><p>Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Andrew Ahmann from the Oregon Health and Science University about the FLAT-SUGAR trial.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-1/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 1</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 2, Issue 1 &#8211; Part  1.</em></p><p>Kathleen Dungan, MD, MPH from The Ohio State University interviews Dr. Andrew Ahmann from the Oregon Health and Science University about the FLAT-SUGAR trial.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-2-1-1/">2015 ADA AND AACE CONFERENCE HIGHLIGHTS &#8211; Part 1</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Therapeutic Advances in Type 2 Diabetes Treatment</title>
			<itunes:title>Therapeutic Advances in Type 2 Diabetes Treatment</itunes:title>
			<pubDate>Thu, 28 May 2015 06:00:13 GMT</pubDate>
			<itunes:duration>40:01</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D506/media.mp3" length="48017807" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=506</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b6</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b6</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKFGYtYEeF6ZU5dSrsMc0Og]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 12. Nestoras Mathioudakis, MD, Assistant Professor of Medicine, and Om Ganda, MD, Associate Professor of Medicine cover the important topic of therapeutic advances in type 2 diabetes treatment in the format of case-study scenarios for t...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 12.</em></p><p>Nestoras Mathioudakis, MD, Assistant Professor of Medicine, and Om Ganda, MD, Associate Professor of Medicine cover the important topic of therapeutic advances in type 2 diabetes treatment in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-12/">Therapeutic Advances in Type 2 Diabetes Treatment</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 12.</em></p><p>Nestoras Mathioudakis, MD, Assistant Professor of Medicine, and Om Ganda, MD, Associate Professor of Medicine cover the important topic of therapeutic advances in type 2 diabetes treatment in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-12/">Therapeutic Advances in Type 2 Diabetes Treatment</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Management of Overweight and Obese Patients with T2DM</title>
			<itunes:title>Management of Overweight and Obese Patients with T2DM</itunes:title>
			<pubDate>Tue, 30 Dec 2014 06:00:32 GMT</pubDate>
			<itunes:duration>31:10</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D508/media.mp3" length="37405817" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=508</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b7</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b7</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRIWGbCLlkts/ixBb4oA4o/h]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 10. Dr. Clare J. Lee from Johns Hopkins University School of Medicine, covers the important topic of the management of overweight and obese patients with type 2 diabetes.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 10.</em></p><p>Dr. Clare J. Lee from Johns Hopkins University School of Medicine, covers the important topic of the management of overweight and obese patients with type 2 diabetes.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-10/">Management of Overweight and Obese Patients with T2DM</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 10.</em></p><p>Dr. Clare J. Lee from Johns Hopkins University School of Medicine, covers the important topic of the management of overweight and obese patients with type 2 diabetes.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-10/">Management of Overweight and Obese Patients with T2DM</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES</title>
			<itunes:title>ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES</itunes:title>
			<pubDate>Thu, 30 Oct 2014 06:00:27 GMT</pubDate>
			<itunes:duration>32:50</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D510/media.mp3" length="39400534" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=510</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b8</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b8</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRJUbF6GnSguO0atpBz/xcHy]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 8. Rajesh Garg, MD, Assistant Professor of Medicine, covers the important topic of the role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes in the format of case-study scenarios for the clinical practice.</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 8.</em></p><p>Rajesh Garg, MD, Assistant Professor of Medicine, covers the important topic of the role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-8/">ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 8.</em></p><p>Rajesh Garg, MD, Assistant Professor of Medicine, covers the important topic of the role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-8/">ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Strategies and Devices for Improving Self-Monitoring</title>
			<itunes:title>Strategies and Devices for Improving Self-Monitoring</itunes:title>
			<pubDate>Thu, 28 Aug 2014 06:00:04 GMT</pubDate>
			<itunes:duration>31:02</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D512/media.mp3" length="37241773" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=512</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331b9</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331b9</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRIqVkKNjtZMvrilAW5l/Waj]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 6. Susan Porter, MSN, CRNP, CDE, Clinical Nurse Practitioner and Certified Diabetes Educator, covers the important topic of strategies and devices for improving self-monitoring in the format of case-study scenarios for the clinical prac...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 6.</em></p><p>Susan Porter, MSN, CRNP, CDE, Clinical Nurse Practitioner and Certified Diabetes Educator, covers the important topic of strategies and devices for improving self-monitoring in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-6/">Strategies and Devices for Improving Self-Monitoring</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 6.</em></p><p>Susan Porter, MSN, CRNP, CDE, Clinical Nurse Practitioner and Certified Diabetes Educator, covers the important topic of strategies and devices for improving self-monitoring in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-6/">Strategies and Devices for Improving Self-Monitoring</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>CVD RISK FACTORS IN PATIENTS WITH T2D</title>
			<itunes:title>CVD RISK FACTORS IN PATIENTS WITH T2D</itunes:title>
			<pubDate>Tue, 08 Jul 2014 06:00:14 GMT</pubDate>
			<itunes:duration>31:07</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D514/media.mp3" length="37343128" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=514</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331ba</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331ba</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRLGzO2aw2dLg6jpBrfs6Eb+]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 4. Om Ganda, MD, Associate Professor of Medicine at Harvard Medical School, and Senior Physician and Director, Lipid Clinic, and Chair, Clinical Oversight Committee at the Joslin Diabetes Center in Boston,</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 4.</em></p><p>Om Ganda, MD, Associate Professor of Medicine at Harvard Medical School, and Senior Physician and Director, Lipid Clinic, and Chair, Clinical Oversight Committee at the Joslin Diabetes Center in Boston, Massachusetts discusses the important topic of CVD risk factors in patients with T2D in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-4/">CVD RISK FACTORS IN PATIENTS WITH T2D</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 4.</em></p><p>Om Ganda, MD, Associate Professor of Medicine at Harvard Medical School, and Senior Physician and Director, Lipid Clinic, and Chair, Clinical Oversight Committee at the Joslin Diabetes Center in Boston, Massachusetts discusses the important topic of CVD risk factors in patients with T2D in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-4/">CVD RISK FACTORS IN PATIENTS WITH T2D</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Strategies For Intensifying Therapy For Glycemic Control</title>
			<itunes:title>Strategies For Intensifying Therapy For Glycemic Control</itunes:title>
			<pubDate>Wed, 30 Apr 2014 06:00:09 GMT</pubDate>
			<itunes:duration>37:40</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/5fa6e50e5686194f10370b5d/e/https%3A%2F%2Fpodcast.dkbmed.com%2F%3Fp%3D516/media.mp3" length="45204423" type="audio/mpeg"/>
			<guid isPermaLink="false">https://podcast.dkbmed.com/?p=516</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/ediabetesreview/episodes/5fa6e5164a2a5c52d1e331bb</link>
			<acast:episodeId>5fa6e5164a2a5c52d1e331bb</acast:episodeId>
			<acast:showId>5fa6e50e5686194f10370b5d</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZ/Ynvgc/bVSlxbfa1LTdZ/NS0G6+1uBWmuf3KXrHlJ0izxnDClosxN1ZvN1RuhNrkdm1oiNHHCHJEX+nOyUFY/3jPCT1l6d4yzX6pQyt9MPxHrrY4Hp2lUexJZii95tRKK/0GzuDF8tcJAI3r2EzF8]]></acast:settings>
			<itunes:subtitle>Volume 1, Issue 2. Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism and Associate Director, Inpatient Diabetes Management at the Johns Hopkins University School of Medicine discusses glycem...</itunes:subtitle>
			<itunes:image href="https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg"/>
			<description><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 2.</em></p><p>Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism and Associate Director, Inpatient Diabetes Management at the Johns Hopkins University School of Medicine discusses glycemic control and strategies to intensify therapy in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-2/">Strategies For Intensifying Therapy For Glycemic Control</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p style="text-align: right;"><em>Volume 1, Issue 2.</em></p><p>Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism and Associate Director, Inpatient Diabetes Management at the Johns Hopkins University School of Medicine discusses glycemic control and strategies to intensify therapy in the format of case-study scenarios for the clinical practice.</p><p>The post <a rel="nofollow" href="https://podcast.dkbmed.com/ediabetes-1-2/">Strategies For Intensifying Therapy For Glycemic Control</a> appeared first on <a rel="nofollow" href="https://podcast.dkbmed.com">DKBmed Radio</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<itunes:category text="Health &amp; Fitness">
			<itunes:category text="Medicine"/>
		</itunes:category>
    </channel>
</rss>
